chr21-46119031-G-C
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PM2PM5PP3_Strong
The NM_001849.4(COL6A2):āc.1181G>Cā(p.Gly394Ala) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.000000686 in 1,457,758 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G394E) has been classified as Pathogenic.
Frequency
Consequence
NM_001849.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
COL6A2 | NM_001849.4 | c.1181G>C | p.Gly394Ala | missense_variant, splice_region_variant | 14/28 | ENST00000300527.9 | |
COL6A2 | NM_058174.3 | c.1181G>C | p.Gly394Ala | missense_variant, splice_region_variant | 14/28 | ENST00000397763.6 | |
COL6A2 | NM_058175.3 | c.1181G>C | p.Gly394Ala | missense_variant, splice_region_variant | 14/28 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
COL6A2 | ENST00000300527.9 | c.1181G>C | p.Gly394Ala | missense_variant, splice_region_variant | 14/28 | 1 | NM_001849.4 | P1 | |
COL6A2 | ENST00000397763.6 | c.1181G>C | p.Gly394Ala | missense_variant, splice_region_variant | 14/28 | 5 | NM_058174.3 | ||
COL6A2 | ENST00000409416.6 | c.1181G>C | p.Gly394Ala | missense_variant, splice_region_variant | 13/27 | 5 |
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD3 exomes AF: 0.00000401 AC: 1AN: 249540Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135480
GnomAD4 exome AF: 6.86e-7 AC: 1AN: 1457758Hom.: 0 Cov.: 30 AF XY: 0.00000138 AC XY: 1AN XY: 725444
GnomAD4 genome Cov.: 34
ClinVar
Submissions by phenotype
Bethlem myopathy 1A Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 27, 2023 | This sequence change replaces glycine, which is neutral and non-polar, with alanine, which is neutral and non-polar, at codon 394 of the COL6A2 protein (p.Gly394Ala). This variant is present in population databases (rs756966358, gnomAD no frequency). This variant has not been reported in the literature in individuals affected with COL6A2-related conditions. ClinVar contains an entry for this variant (Variation ID: 572135). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. This variant disrupts the triple helix domain of COL6A2. Glycine residues within the Gly-Xaa-Yaa repeats of the triple helix domain are required for the structure and stability of fibrillar collagens (PMID: 7695699, 8218237, 19344236). In COL6A2, missense variants at these glycine residues are significantly enriched in individuals with autosomal dominant disease (PMID: 15689448, 24038877) compared to the general population (ExAC). This variant disrupts the p.Gly394 amino acid residue in COL6A2. Other variant(s) that disrupt this residue have been observed in individuals with COL6A2-related conditions (PMID: 20976770, 24038877), which suggests that this may be a clinically significant amino acid residue. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at